Supernus Pharmaceuticals (SUPN) Q2 2025 Earnings

6MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
0.37
0.64
0.9
1.17

Details

Expected EPS
0.373333
Actual EPS
0.437994
Surprise EPS
0.06
Surprise Percent
+17.32%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.437994 per share for Q2 2025.

0 Comments

Share your thoughts